Clinical trials
Phase 1/2 Hemophilia B trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baxalta now part of Shire | 2 |
| CSL Behring | 2 |
| Spur Therapeutics | 2 |
| ApcinteX Ltd | 1 |
| Avigen | 1 |
| Be Biopharma | 1 |
| Biocad | 1 |
| Genzyme, a Sanofi Company | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| National Center for Research Resources (NCRR) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia B | 18 |
| Hemophilia A | 3 |
| Factor VII Deficiency | 1 |
| Hematologic Diseases | 1 |
| Rare Diseases | 1 |
Trials
Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.